Log in to save to my catalogue

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_597edbae2cab4889bc81b0dac4c2ea09

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

About this item

Full title

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

Publisher

England: BioMed Central Ltd

Journal title

Molecular neurodegeneration, 2023-11, Vol.18 (1), p.83-83, Article 83

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Mitochondrial dysfunction is strongly implicated in the etiology of idiopathic and genetic Parkinson’s disease (PD). However, strategies aimed at ameliorating mitochondrial dysfunction, including antioxidants, antidiabetic drugs, and iron chelators, have failed in disease-modification clinical trials. In this review, we summarize the cellular deter...

Alternative Titles

Full title

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_597edbae2cab4889bc81b0dac4c2ea09

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_597edbae2cab4889bc81b0dac4c2ea09

Other Identifiers

ISSN

1750-1326

E-ISSN

1750-1326

DOI

10.1186/s13024-023-00676-7

How to access this item